Jaws Acquisition Corp. (NYSE:JWS) announced in an 8-K filing this afternoon that its shareholders approved its combination with Cano Health at a special meeting earlier today.
The deal was overwhelmingly approved with 75.1% of shares participating in the vote, and the parties expect the transaction to close tomorrow June 3. Shares and warrants of combined entity are expected to begin trading on the NYSE on June 4 under the symbols “CANO” and “CANO.WS”, respectively.
Jaws did not share redemption figures in its filing, but they are unlikely to be significant as its shares closed at $14.51 on May 28, the day of its redemption deadline. This deal along with Deerfield (NASDAQ:DFHT)’s combination with fellow Medicare Advantage-focused CareMax have both been warmly received as Deerfield also closed at $14.50 today.
The first SPAC deal with a Medicare Advantage player of the past year – Social Capital III’s merger with Clover Health (NASDAQ:CLOV) – has fared less well, generally trading below $10 since late February. But, its performance includes external factors including a short seller report and regulatory probes.
Jaws and Cano initially announced their $4.4 billion deal on November 12. Cano serves more than 103,000 Medicare Advantage patients through 564 primary care physicians in Florida, Texas, Nevada, and Puerto Rico.
Most measures on the shareholders’ ballot passed by wide margins but some governance proposals were more controversial than others with one receiving 37.9% of votes against. For a full list of measures and vote tallies, click HERE.
ADVISORS
- Moelis & Company is acting as financial advisor to Cano Health.
- Credit Suisse is serving as financial advisor and exclusive capital markets advisor to Cano Health. Credit Suisse is also serving as exclusive placement agent on the private offering.
- Goodwin Procter LLP is serving as legal counsel to Cano Health and Cravath Swaine & Moore LLP is serving as counsel to certain shareholders, including members of Company management.
- Kirkland & Ellis LLP is serving as legal counsel to Jaws Acquisition Corp.
At the SPAC of Dawn There are signs that the macro environment for SPACs is gradually improving, but the Screaming Eagle team yesterday announced a non-redemption agreement for its combination with Lionsgate Studios. Such agreements are generally a lever one pulls when a SPAC expects a potentially turbulent closing. All in all, the terms for...
Israeli tech firms have made up an outsized proportion of SPAC activity and despite the ongoing tensions in its region, that dealmaking is continuing unabated. In fact, the SPAC named for the particular mission of taking Israeli firms public through SPACs, Israel Acquisition Corp. (NASDAQ:ISRL) in fact just took one step closer in completing that...
At the SPAC of Dawn Although the market has largely recovered from a negative stretch last week, the roller coaster is tilted back downward for Trump Media (NASDAQ:DJT), which slid -8% yesterday to $32.57 – one of its lowest points since closing with Digital World last month. Other SPACs and de-SPACs are having a more...
Remember the metaverse? Many do not. Meta’s (NASDAQ:META) attempted transition to virtually living and working seemed to mark a trend that went up and down quickly, but one SPAC deal has both survived that roller coaster and may rise with a second. Back in December 2022, Newbury Street (NASDAQ:NBST) announced a $1.85 billion combination with...
At the SPAC of Dawn Tucked into the bill that provides $95 billion in funding to American allies passed by the House this weekend is another measure that is likely to have far more impact on at least one pending deal in SPAC world. It would appear that the timing was fortuitous for TikTok rival...